» Articles » PMID: 38088977

Central Nervous System Tuberculosis: Risk Factors for Mortality in a Propensity Score-Matched Case-Control Study

Overview
Date 2023 Dec 13
PMID 38088977
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite advancements in tuberculosis (TB) control and treatment in the United States (US), patients with central nervous system TB (CNS-TB) continue to experience significantly higher mortality rates than those without CNS-TB. This raises concerns regarding clinical management and the need for a deeper understanding of the risk factors contributing to these deaths. This study aimed to determine the predictors of mortality in patients with CNS-TB.

Methods: We conducted a retrospective 1:2 propensity score-matched case-control study. Cases were TB patients diagnosed with TB of the meninges, brain, spinal cord, or peripheral nerves, as documented in the Florida Department of Health (FDOH) TB registry, between 2009 and 2021. Controls were TB patients without CNS-TB, also reported in the FDOH TB registry during the same timeframe. We employed conditional logistic regression models to investigate the factors contributing to mortality in cases compared with controls.

Results: We analyzed data from 116 cases and 232 matched controls. Patients with CNS-TB had a 5.69-fold higher risk of death than those without CNS-TB (adjusted odds ratio [aOR], 5.69 [95% confidence interval {CI}, 2.91-11.6]). Increased risk of death was associated with human immunodeficiency virus (HIV) coinfection (aOR, 1.93 [95% CI, .82-4.37]) and diabetes (aOR, 3.13 [95% CI, 1.28-7.47]). Miliary TB and non-HIV immunosuppression were significantly associated with being a case, while cavitary TB was less likely to be associated with being a case.

Conclusions: Clinical management should prioritize screening and close monitoring of patients with HIV coinfection and diabetes to improve patient outcomes.

Citing Articles

Numerous Asymptomatic Brain Tuberculomas Complicated by Fatal Tuberculous Meningitis.

Alavidze I, Shubitidze M, Khodeli G, Dvali S, Tskitishvili A Cureus. 2024; 16(6):e63090.

PMID: 39055453 PMC: 11270632. DOI: 10.7759/cureus.63090.


The application value of cerebrospinal fluid immunoglobulin in tuberculous meningitis.

He H, Xu J, Peng Q, Li Y, Huang Y, Zhang Y Microbiol Spectr. 2024; 12(6):e0015724.

PMID: 38666897 PMC: 11237685. DOI: 10.1128/spectrum.00157-24.

References
1.
Brancusi F, Farrar J, Heemskerk D . Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol. 2012; 7(9):1101-16. DOI: 10.2217/fmb.12.86. View

2.
Faksri K, Xia E, Ong R, Tan J, Nonghanphithak D, Makhao N . Comparative whole-genome sequence analysis of Mycobacterium tuberculosis isolated from tuberculous meningitis and pulmonary tuberculosis patients. Sci Rep. 2018; 8(1):4910. PMC: 5861094. DOI: 10.1038/s41598-018-23337-y. View

3.
Filardo T, Feng P, Pratt R, Price S, Self J . Tuberculosis - United States, 2021. MMWR Morb Mortal Wkly Rep. 2022; 71(12):441-446. PMC: 8956339. DOI: 10.15585/mmwr.mm7112a1. View

4.
Yasar K, Pehlivanoglu F, Sengoz G . Predictors of mortality in tuberculous meningitis: a multivariate analysis of 160 cases. Int J Tuberc Lung Dis. 2010; 14(10):1330-5. View

5.
Seddon J, Tugume L, Solomons R, Prasad K, Bahr N . The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome Open Res. 2020; 4:167. PMC: 7029758. DOI: 10.12688/wellcomeopenres.15535.1. View